Cite
HARVARD Citation
Kanemasa, Y. et al. (n.d.). Beta‐2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B‐cell lymphoma. Hematological oncology. 35 (4), pp. 440-446. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kanemasa, Y. et al. (n.d.). Beta‐2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B‐cell lymphoma. Hematological oncology. 35 (4), pp. 440-446. [Online].